Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype.

Details

Serval ID
serval:BIB_E766AC88BDBF
Type
Article: article from journal or magazin.
Publication sub-type
Letter (letter): Communication to the publisher.
Collection
Publications
Title
Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype.
Journal
Hepatology
Author(s)
Thompson A.J., Muir A.J., Sulkowski M.S., Patel K., Tillmann H.L., Clark P.J., Naggie S., Fellay J., Ge D., McCarthy J.J., Goldstein D.B., McHutchison J.G.
ISSN
1527-3350 (Electronic)
ISSN-L
0270-9139
Publication state
Published
Issued date
2010
Volume
52
Number
6
Pages
2243-2244
Language
english
Notes
Publication types: Comment ; Letter
Keywords
Antiviral Agents/therapeutic use, Clinical Trials as Topic/methods, Hepacivirus/genetics, Hepatitis C/drug therapy, Hepatitis C/genetics, Humans, Interferon-alpha/therapeutic use, Interleukins/genetics, Polyethylene Glycols/therapeutic use, Recombinant Proteins
Pubmed
Web of science
Open Access
Yes
Create date
01/03/2012 15:14
Last modification date
20/08/2019 16:10
Usage data